Why I Pioneer
25 years of bigger leaps
For 25 years, Flagship Pioneering has endeavored to make the impossible possible, pushing the boundaries of knowledge to pioneer a better future for people and the planet.
We are celebrating not just the breakthroughs we’ve achieved, but the people who make them happen. Through these stories, we share the passion and purpose that shape our culture of fearless exploration and discovery.
Pioneering Partnerships
Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines
Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease
Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease
Valo Health and Novo Nordisk Expand Collaboration to Discover and Develop Novel Treatments for Cardiometabolic Diseases
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
Our Companies
- Moderna Founded: 2010
- Tessera Therapeutics Founded: 2018
- Generate:Biomedicines Founded: 2018
- Inari Agriculture Founded: 2016
- Quotient Therapeutics Founded: 2022
- Lila Sciences Founded: 2023
Latest News
- Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines 05.20.2025
- Ted Myles Joins Cellarity as Chief Executive Officer 05.12.2025
- Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development 05.07.2025
- Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics 04.29.2025
- Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare 04.24.2025
- Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease 04.23.2025
Employee Spotlight
Off the Clock with Flagship Employees
Amanda Kay on a New Approach to Biopharma Partnerships
Companies founded
100+
